Menu

Markets

Research

News

Learn
Paper trading
AI Chat
WatchlistsPortfoliosAlerts
Sign in

AZN

AstraZeneca PLC

Healthcare · USD

Set alert

Price alert · AZN

All alert types
186.65 USD +12.25 +7.02%
As of Oct 30, 2026 Extended hours 186.35 -0.16%
Bid
186.63 × 100
Ask
186.75 × 300
183.10 Day range 188.39
155.62 52-week range 209.48
YTD
+1.52%
1 year
+13.34%
Open
183.59
Prev close
174.40
Mkt cap
289.48B
Vol
5.47M
Avg vol
3.41M
EPS
6.69
P/E
27.90
Div yield
1.84%
More statistics
Low
183.10
High
188.39
Forward P/E
16.41
Beta
0.21
Short ratio
1.14
Inst. own
76.35%
Dividend
3.20
Ex-div date
Aug 6, 2026
Earnings
Feb 9, 2027
50-d avg
164.04
200-d avg
180.19
1y target
206.66

5D chart

Chart tools
Interval
1m5m15m30m
AZN five-day price chart168.0173.1178.2183.3188.4Oct 26Oct 27Oct 28Oct 29Oct 30

Financial health

Altman Z-Score

3.71 Safe zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

8 / 9 Strong

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

B+3 / 5 overall

  • DCF 5
  • Return on Equity 5
  • Return on Assets 5
  • Debt / Equity 1
  • P/E 2
  • P/B 1

Valuation

P/E 26.6×
FY 2016: 19.4×FY 2017: 28.9×FY 2018: 44.7×FY 2019: 98.1×FY 2020: 41.4×FY 2021: 1448×FY 2022: 64.3×FY 2023: 34.9×FY 2024: 28.6×FY 2025: 26.6×
FY 2016 5y median 34.9× FY 2025
P/S 4.6×
FY 2016: 3.0×FY 2017: 3.9×FY 2018: 4.4×FY 2019: 5.4×FY 2020: 5.0×FY 2021: 4.4×FY 2022: 4.8×FY 2023: 4.5×FY 2024: 3.7×FY 2025: 4.6×
FY 2016 5y median 4.5× FY 2025
P/B 5.6×
FY 2016: 4.6×FY 2017: 5.8×FY 2018: 7.7×FY 2019: 10.0×FY 2020: 8.5×FY 2021: 4.2×FY 2022: 5.7×FY 2023: 5.3×FY 2024: 4.9×FY 2025: 5.6×
FY 2016 5y median 5.3× FY 2025
P/FCF 31.4×
FY 2016: 37.2×FY 2017: 44.3×FY 2018: 77.2×FY 2019: 258×FY 2020: 60.4×FY 2021: 43.7×FY 2022: 29.1×FY 2023: 31.6×FY 2024: 27.7×FY 2025: 31.4×
FY 2016 5y median 31.4× FY 2025
EV/EBITDA 14.9×
FY 2016: 11.0×FY 2017: 15.3×FY 2018: 15.5×FY 2019: 21.5×FY 2020: 17.9×FY 2021: 36.9×FY 2022: 25.7×FY 2023: 17.2×FY 2024: 14.6×FY 2025: 14.9×
FY 2016 5y median 17.2× FY 2025
EV/Sales 5.0×
FY 2016: 3.5×FY 2017: 4.5×FY 2018: 5.0×FY 2019: 5.9×FY 2020: 5.4×FY 2021: 5.0×FY 2022: 5.3×FY 2023: 5.0×FY 2024: 4.2×FY 2025: 5.0×
FY 2016 5y median 5.0× FY 2025
FCF Yield 3.2%
FY 2016: 2.7%FY 2017: 2.3%FY 2018: 1.3%FY 2019: 0.4%FY 2020: 1.7%FY 2021: 2.3%FY 2022: 3.4%FY 2023: 3.2%FY 2024: 3.6%FY 2025: 3.2%
FY 2016 5y median 3.2% FY 2025

Profitability

Gross Margin 81.9%
FY 2016: 82.1%FY 2017: 80.8%FY 2018: 77.7%FY 2019: 79.8%FY 2020: 80.1%FY 2021: 66.8%FY 2022: 72.1%FY 2023: 82.0%FY 2024: 81.1%FY 2025: 81.9%
FY 2016 5y median 81.1% FY 2025
Operating Margin 23.4%
FY 2016: 21.3%FY 2017: 16.4%FY 2018: 15.3%FY 2019: 12.0%FY 2020: 19.4%FY 2021: 2.8%FY 2022: 8.5%FY 2023: 17.9%FY 2024: 18.5%FY 2025: 23.4%
FY 2016 5y median 17.9% FY 2025
Net Margin 17.5%
FY 2016: 15.2%FY 2017: 13.4%FY 2018: 9.8%FY 2019: 5.5%FY 2020: 12.0%FY 2021: 0.3%FY 2022: 7.4%FY 2023: 13.0%FY 2024: 13.0%FY 2025: 17.5%
FY 2016 5y median 13.0% FY 2025
ROE 21.1%
FY 2016: 23.6%FY 2017: 20.1%FY 2018: 17.3%FY 2019: 10.2%FY 2020: 20.5%FY 2021: 0.3%FY 2022: 8.9%FY 2023: 15.2%FY 2024: 17.2%FY 2025: 21.1%
FY 2016 5y median 15.2% FY 2025
ROIC 13.0%
FY 2016: 9.5%FY 2017: 7.5%FY 2018: 7.3%FY 2019: 5.1%FY 2020: 8.5%FY 2021: -0.5%FY 2022: 5.0%FY 2023: 9.3%FY 2024: 10.3%FY 2025: 13.0%
FY 2016 5y median 9.3% FY 2025
ROA 9.0%
FY 2016: 5.6%FY 2017: 4.7%FY 2018: 3.6%FY 2019: 2.2%FY 2020: 4.8%FY 2021: 0.1%FY 2022: 3.4%FY 2023: 5.9%FY 2024: 6.8%FY 2025: 9.0%
FY 2016 5y median 5.9% FY 2025

Growth (YoY)

Revenue 8.6%
FY 2016: -6.9%FY 2017: -2.3%FY 2018: -1.7%FY 2019: 10.4%FY 2020: 9.2%FY 2021: 40.6%FY 2022: 18.5%FY 2023: 3.3%FY 2024: 18.0%FY 2025: 8.6%
FY 2016 FY 2025
Operating Income 37.4%
FY 2016: 19.2%FY 2017: -25.0%FY 2018: -7.9%FY 2019: -13.7%FY 2020: 76.5%FY 2021: -79.5%FY 2022: 255.8%FY 2023: 118.1%FY 2024: 22.1%FY 2025: 37.4%
FY 2016 FY 2025
EPS (diluted) 45.3%
FY 2016: 23.8%FY 2017: -14.1%FY 2018: -28.3%FY 2019: -39.4%FY 2020: 136.9%FY 2021: -96.7%FY 2022: 2537.5%FY 2023: 80.6%FY 2024: 18.1%FY 2025: 45.3%
FY 2016 FY 2025
Free Cash Flow 19.2%
FY 2016: 241.6%FY 2017: 6.9%FY 2018: -36.3%FY 2019: -59.2%FY 2020: 330.8%FY 2021: 71.6%FY 2022: 92.3%FY 2023: -9.3%FY 2024: 10.8%FY 2025: 19.2%
FY 2016 FY 2025

Financial Health

Current Ratio 0.9×
FY 2016: 0.9×FY 2017: 0.8×FY 2018: 1.0×FY 2019: 0.9×FY 2020: 1.0×FY 2021: 1.2×FY 2022: 0.9×FY 2023: 0.8×FY 2024: 0.9×FY 2025: 0.9×
FY 2016 5y median 0.9× FY 2025
Quick Ratio 0.7×
FY 2016: 0.7×FY 2017: 0.6×FY 2018: 0.8×FY 2019: 0.7×FY 2020: 0.8×FY 2021: 0.8×FY 2022: 0.7×FY 2023: 0.6×FY 2024: 0.7×FY 2025: 0.7×
FY 2016 5y median 0.7× FY 2025
Debt / Equity 0.6×
FY 2016: 1.1×FY 2017: 1.2×FY 2018: 1.5×FY 2019: 1.4×FY 2020: 1.3×FY 2021: 0.8×FY 2022: 0.8×FY 2023: 0.7×FY 2024: 0.7×FY 2025: 0.6×
FY 2016 5y median 0.7× FY 2025
Net Debt / EBITDA 1.2×
FY 2016: 1.6×FY 2017: 2.2×FY 2018: 2.0×FY 2019: 1.9×FY 2020: 1.6×FY 2021: 4.8×FY 2022: 2.5×FY 2023: 1.7×FY 2024: 1.6×FY 2025: 1.2×
FY 2016 5y median 1.7× FY 2025
Interest Coverage 8.1×
FY 2016: 3.6×FY 2017: 2.7×FY 2018: 2.5×FY 2019: 2.1×FY 2020: 4.1×FY 2021: 0.8×FY 2022: 2.8×FY 2023: 5.2×FY 2024: 5.9×FY 2025: 8.1×
FY 2016 5y median 5.2× FY 2025

Dividends

Dividend Yield 1.8%
FY 2016: 5.2%FY 2017: 4.1%FY 2018: 3.6%FY 2019: 2.7%FY 2020: 2.7%FY 2021: 2.3%FY 2022: 2.1%FY 2023: 2.2%FY 2024: 2.3%FY 2025: 1.8%
FY 2016 5y median 2.2% FY 2025
Payout Ratio 48.5%
FY 2016: 101.8%FY 2017: 117.3%FY 2018: 161.7%FY 2019: 269.1%FY 2020: 111.8%FY 2021: 3442.9%FY 2022: 132.7%FY 2023: 75.2%FY 2024: 65.8%FY 2025: 48.5%
FY 2016 5y median 75.2% FY 2025

Annual · latest fiscal year ends 2025-12-31